NTI drug but with high CV [Power / Sample Size]

posted by Mikalai  – Belarus, 2019-12-14 15:39 (403 d 07:35 ago) – Posting: # 20975
Views: 1,674

Dear all.
What would be a sample size for a BE study when the CV of the drug is 30% but bioequivalence should be in range 90_110%? Our assumption is around 400 subject if the design is standard, and 200 if the design is replicative
Best regards.

Complete thread:

Activity
 Admin contact
21,308 posts in 4,444 threads, 1,489 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Wednesday 23:14 CET (Europe/Vienna)

Power: That which is wielded by the priesthood of
clinical trials, the statisticians, and a stick which they use
to beta their colleagues.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5